Chemomab Therapeutics Ltd.
CMMB
$1.23
$0.000.00%
NASDAQ
| 12/31/2023 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -7.43% | -7.43% | -19.62% | -18.70% | -18.02% |
| Total Receivables | -68.66% | -68.66% | -11.52% | 4.72% | 116.78% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 5.56% | 5.56% | -2.70% | -3.90% | 0.00% |
| Total Current Assets | -6.57% | -6.57% | -19.27% | -17.98% | -19.07% |
|
|
|||||
| Total Current Assets | -6.57% | -6.57% | -19.27% | -17.98% | -19.07% |
| Net Property, Plant & Equipment | 54.79% | 54.79% | -9.84% | -8.62% | -8.25% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -7.30% | -7.30% | -6.66% | -6.38% | -5.87% |
| Total Assets | -5.41% | -5.41% | -18.83% | -17.60% | -18.69% |
|
|
|||||
| Total Accounts Payable | -29.41% | -29.41% | -68.85% | 5.86% | 31.34% |
| Total Accrued Expenses | -6.35% | -6.35% | 3.75% | -6.32% | -5.53% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -27.62% | -27.62% | -2.78% | -6.09% | -6.50% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -9.91% | -9.91% | -21.32% | -2.46% | 3.67% |
|
|
|||||
| Total Current Liabilities | -9.91% | -9.91% | -21.32% | -2.46% | 3.67% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 6,220.00% | 6,220.00% | -84.85% | -46.77% | -31.87% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -4.11% | -4.11% | -21.62% | -2.85% | 3.20% |
|
|
|||||
| Common Stock & APIC | 1.72% | 1.72% | 0.13% | 1.97% | 0.48% |
| Retained Earnings | -4.79% | -4.79% | -5.07% | -10.98% | -13.72% |
| Treasury Stock & Other | -- | -- | 0.00% | 0.00% | 0.00% |
| Total Common Equity | -5.80% | -5.80% | -17.95% | -21.33% | -22.83% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -5.80% | -5.80% | -17.95% | -21.33% | -22.83% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -5.80% | -5.80% | -17.95% | -21.33% | -22.83% |
|
|
|||||